Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Benzodiazepines and medications acting on benzodiazepine receptors that do not have a benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory bodies as having limited benefit and significant risks. Data presented in this article support the use of these medications as treatments of choice for acute situational anxiety, chronic anxiety disorders, insomnia, alcohol withdrawal syndromes, and catatonia. They may also be useful adjuncts in the treatment of anxious depression and mania, and for medically ill patients. Tolerance develops to sedation and possibly psychomotor impairment, but not to the anxiolytic effect of benzodiazepines. Sedation can impair cognitive function in some patients, but assertions that benzodiazepines increase the risk of dementia are not supported by recent data. Contrary to popular opinion, benzodiazepines are not frequently misused or conduits to misuse of other substances in patients without substance use disorders who are prescribed these medications for appropriate indications; most benzodiazepine misuse involves medications that are obtained from other people. Benzodiazepines are usually not lethal in overdose except when ingested with other substances, especially alcohol and opioids. Benzodiazepines comprise one of the few classes of psychotropic medication the mechanisms of action of which are clearly delineated, allowing for greater precision in their clinical use. These medications, therefore, belong in the therapeutic armamentarium of the knowledgeable clinician.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After several decades of use, Benzodiazepines and Benzodiazepine Receptor Agonists remain important therapeutic options for the treatment of mental health related concerns such as anxiety and sleep disorders.1”
Citations
Cites
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Tromp, A. M., Pluijm, S. M. F., Smit, J. H., Deeg, D. J. H., Bouter, L. M., & Lips, P. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00349-3 · Cited by 666
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Geffrey, A. L., Pollack, S. F., Bruno, P. L., & Thiele, E. A. (2015) · Epilepsia · doi:10.1111/epi.13060 · Cited by 496
Slee, A., Nazareth, I., Bondaronek, P., Liu, Y., Cheng, Z., & Freemantle, N. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31793-8 · Cited by 372
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Dolovich, L. R., Addis, A., Vaillancourt, J. M. R., Power, J. D. B., Koren, G., & Einarson, T. R. (1998) · BMJ · doi:10.1136/bmj.317.7162.839 · Cited by 353
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317
Paradoxical reactions to benzodiazepines: literature review and treatment options
Mancuso, C. E., Tanzi, M. G., & Gabay, M. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1177.38089 · Cited by 298
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Research works printed but not linked: 1
- 10.1080/15622975.2018.1500031 · DOI · Paper page
Cited by
Items 101–171 of 171
Kandalkar, M., & Sharma, P. (2023) · Asian Journal of Chemistry · doi:10.14233/ajchem.2023.27891 · Cited by 1
Vaaler, A. (2022) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.22.0563
Balon, R. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000528352
Keeping Politics out of Doctors’ Offices: A Reply to Fogelson
Dubovsky, S. L. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000528523
Self-citationBenzodiazepines in Psychiatric Disorder Management: The Safe Ways to Use
Kar, S. K. (2023) · Academic Bulletin of Mental Health · doi:10.25259/abmh_7_2023
Impacto toxicológico en muertes asociadas por benzodiacepinas, fentanilo y sus análogos
Matamoros, A. F. M., & Jerez, M. A. J. (2023) · Revista Medica Sinergia · doi:10.31434/rms.v8i11.1111 · Cited by 1
Treatment of delirious mania with catatonia in a community teaching hospital: A case series
Wheeler, T., & Vasan, S. (2023) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2023.100190
GABAERGIC MODULATION IN THE FORMATION OF DECLARATIVE MEMORY AND FACE RECOGNITIONPreprint
León, C. S., Celso, A. L., Benítez, F. A. U., Bonilla, M., Olivar, N., Toledo, J., Brusco, L. I., & Forcato, C. (2023) · doi:10.31234/osf.io/dn2c3
Rocky, N. A. R. M., & Chemi, N. B. (2023) · The Malaysian Journal of Nursing · doi:10.31674/mjn.2023.v15isupp1.003
Anusevičius, Ž., Kosychova, L., Kairys, V., Krikštopaitis, K., & Šarlauskas, J. (2023) · doi:10.3390/ecsoc-27-16162
Study on the Chemical Compositions, Anti-Insomnia Effect and Mechanism of Prunella Vulgaris LPreprint
Zhou, C., Zhang, Y., Wang, C., Liao, X.-J., Hu, Y.-F., Cheng, F., & Jiang, Y. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4653982
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments
Serretti, A. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000547
Toxicities and toxicodynamic of anesthetics
Kaur, S., Abubakar, M., Dutta, B. J., Pawar, B. M., Tekade, M., Pingale, P., & Tekade, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15842-1.00009-0
de Lima, A. C., Diniz, Í. F. D. S., da Silva, B. P., de Azevedo, M. D. G. B., & de Souza, J. B. P. (2024) · Saúde e meio ambiente revista interdisciplinar · doi:10.24302/sma.v13.5115
Gao, X. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/44/20240941
Cognitive-Behavioral Therapy Targeted to the Successful Discontinuation of Benzodiazepine Medication
Long, L. J., Parsons, E. M., & Otto, M. W. (2024) · CBT: science into practice · doi:10.1007/978-3-031-62971-6_10
Zumu, F. S., Akbor, M. S., Amin, A. A., Haque, M. F., Sultana, I., Faruq, A. A., Domiciano, C. B., Coutinho, H. D. M., & Islam, M. T. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100108
Elewa, N. Z., Khairy, M. H., Ahmed, A. M., Abdelaty, A. I., Amro, A., & Zeid, E. H. A. (2024) · Research Square · doi:10.21203/rs.3.rs-5338696/v1
Muenks, A., Farrell, D. P., Zhou, G., & DiMaio, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.20.623795
Zeid, E. H. A. (2024) · Research Square · doi:10.21203/rs.3.rs-5338696/v2
Fava, G. A. (2025) · The International Library of Bioethics · doi:10.1007/978-94-024-2274-0_11
Elkan, E.-M., Dănilă, D. M., Alexandru, O. –. C., Pusica, Z., Cobzaru, A.-M., Ilie, L., LUNGU, I., Duceac, L. D., Stan, B.-C., & Ciubară, A. (2025) · BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE · doi:10.70594/brain/16.s1/29
Anxiety treatment: Updated options
Sivolap, Y. P., & Portnova, A. A. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-130
IMPACTO DO USO PROLONGADO DE BENZODIAZEPÍNICOS NA SAÚDE FÍSICA E MENTAL DOS PACIENTES
Brasileiro, B. H. V., de Sousa, L. V. M., & Azevedo, P. S. D. S. (2025) · Revista Contemporânea · doi:10.56083/rcv5n5-021
Benzodiazepines: a descriptive study of prescription patterns in Tabriz, Iran, 2021–2022
Fakhari, A., Farahbakhsh, M., Matinkia, M., Khameneh, A., Azimian, A., & Aghajani, E. (2025) · Discover Health Systems · doi:10.1007/s44250-025-00245-3
Brunetti, P., & Giorgetti, A. (2025) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2025.05.001
Štiglić, M. K., Strbad, T., Belančić, A., Mršić‐Pelčić, J., & Vitezić, D. (2025) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riaf051
Benzodiazepines and Z-Drugs in Pregnancy
Bellantuono, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-99720-4_12
The Relationship between Thyroid Dysfunction and Bipolar Disorder
Skryabin, V. Y., Sokolova, S. I., & Petrovskiy, V. P. (2025) · Psikhiatriya · doi:10.30629/2618-6667-2025-23-3-97-110
Schepis, T. S., Veliz, P. T., West, B. T., Ford, J. A., & McCabe, S. E. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251370827
Тревожные расстройства: современные стратегии терапии и место бензодиазепинов
Скугаревская, М. М. (2025) · Рецепт · doi:10.34883/pi.2025.28.5.002
Zhao, Y., Ma, X., & Zheng, Q. (2025) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2025.113162
Chapter 7. Sedatives, Hypnotics, or Anxiolytics
Blazes, C. K., & Leung, S. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg07
Ayala, J. R. S., Armas, D. A., García, V. H., Aguirre‐Jaime, A., Gutiérrez, A. J., Paz, S., de la Torre, A. H., & Rubio, C. (2025) · Pharmacy · doi:10.3390/pharmacy13060181 · Cited by 1
Riabchenko, M. A., Rutkovskiy, R. V., & Leyderman, I. N. (2025) · Clinical nutrition and metabolism · doi:10.17816/clinutr696525
Stein, D. J., Kazdin, A. E., Baldwin, D. S., Harris, M., Hwang, I. H., Pozuelo, J. R., Sampson, N. A., Woodruff, P. W. R., Viana, M. C., Aguilar‐Gaxiola, S., et al. (2025) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70031
Tuapanta, M. P. P., & Molina, W. E. M. (2026) · Esprint Investigación · doi:10.61347/ei.v5i1.241
Evaluation of Rohypnol-Induced Acute Neurotoxicity in Male Wistar Rats
Salami, B. A., Umezurike, E. T., Adeyemi-Ekeolu, B., Orabuego, A. U., Adedokun, S. A., & Akinde, K. M. (2026) · European Journal of Medical and Health Research · doi:10.59324/ejmhr.2026.4(1).31
Chang, Y., Liu, M., Liu, Y., Xie, X., & Zhang, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-39359-w
Wang, Y., Yang, L., Wu, X., He, Y., Wang, S., Yang, T., Mou, F., Chen, J., & Fang, Y. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121401
Addiction to Nonalcohol Sedative-Hypnotics and Anxiolytics
Siddiqui, M., & Dumas, E. (2026) · Springer eBooks · doi:10.1007/978-3-031-57159-6_3-1
Hamadieh, Z., Goldfarb, D. G., & Ellendon, N. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07931-3
Santaya, M., Warlick, H., Chandramohan, C., Chandramohan, P., Jafarmadar, A., Joubran, E., Koleng, M., Owens-Charles, C. R., Rodriguez, J. R., Sardinas, M., et al. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11660-x
Psychische Störungen im höheren Lebensalter – ohne Demenzerkrankungen
Haupt, M., Wolter, D. K., & Gutzmann, H. (2026) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_91-2
A Python-powered QSPR framework for benzodiazepine analysis using topological indices
Ghezelahmad, S. K., & Rouhani, M. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103280
Safety of Anxiolytics: Analyzing the Russian Database of Spontaneous Reports
Gomon, Y. М., Анатольевна, Л. В., Колбин, А. С., Горелов, К. В., & Незнанов, Н. Г. (2026) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2026-540
Effects of Long-Term Consumption of Anxiolytics, Antidepressants, and Hypnotics on Working Memory
Cansino, S., Torres-Trejo, F., Estrada-Manilla, C., & RUIZ-VELASCO, S. (2026) · Experimental Aging Research · doi:10.1080/0361073x.2026.2652815
Analysis of Psychotropic Drug Utilization in Patients With Organic Mental Disorders
Yuliawati, Y., Sofyan, I. S. W., Sadli, N. K., & Kasmadi, F. (2026) · Sciences of Pharmacy · doi:10.58920/sciphar0502576
A case report of malignant catatonia in a patient with apparent intoxication
Theobald, T. E., Sayed, O., Pettis, C., Klinger, J. A., & Baker, S. P. (2026) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2026.04.011
Galdieri, D. A., Nolder, K. A., Mahoney, C., & Anderson, K. G. (2026) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2026.174198
Case Studies and Patents in Alzheimer’s Disease Research
Kumar, D., Anand, P., Tiwari, J., & Singh, S. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010016
Chalcones as versatile intermediates in organic chemistry
Clemente, F., Capperucci, A., & Tanini, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43812-7.00017-4
Shen, T., Yin, X., Zhang, Y., Wang, F., Wang, H., Shi, X., 邱广淼, Li, J., & Du, X. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08202-x · Cited by 1
Brandt, J., Lamberson, N., Bressi, J., Ritvo, A. D., Curle, J., Witt-Doerring, J., DeWert, M., Wright, S., & Horowitz, M. A. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261457547
Anxiolytic and sedative drugs: Sleep modulation and memory implications
Marcoccia, S., Chiacchierini, G., & Campolongo, P. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111793
Association between Hypnotic Use and the Risk of Alzheimer’s Disease
王, 妍. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1672493
Vaarankorpi, M., Valkonen, V., & Karttunen, N. M. (2026) · Nordic Studies on Alcohol and Drugs · doi:10.1177/14550725261463002 · Cited by 1
McIntyre, R. S., Kato, M., Thase, M. E., Therrien, F., Marrache, A. M., Ikehara, K., Ardic, F. C., & Boucher, M. (2026) · CNS Drugs · doi:10.1007/s40263-026-01315-7 · Cited by 1
Anxiolytics, sedatives, and antidepressants
Markotić, A., & Pavlović, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30050-9.00012-6 · Cited by 1
Frites, W., Chebrouk, F., Cherfaoui, B., Khalfaoui, M., Boudjenouia, N., Chaima, M., Hammal, L., & Boulebd, H. (2026) · ChemistrySelect · doi:10.1002/slct.74047
Wolter, D. K., & Mühlig, S. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21155-3.00019-8
McKay, A. J., Naik, K., & Chakrabarti, S. (2026) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.70014
Antypenko, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10753552/v1
Bershak, A. Y., Antypenko, L., Kopteva, S. D., Nataly, B., Belenichev, I. F., Bukhtiyarova, N. V., Okovytyy, S. I., & Коваленко, С. І. (2026) · Research Square · doi:10.21203/rs.3.rs-10753552/v2
Dybowski, M. P., & Siwek, K. J. (2026) · Journal of Separation Science · doi:10.1002/jssc.70517
Pui, S., Chu, W., & 高希言 (2026) · Acupuncture & Electro-Therapeutics Research · doi:10.1177/03601293261487813
Defining Near-Term Treatment Goals for Benzodiazepine Use in Clinical Practice
Parikh, A., Russell, G., & Olfson, M. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260426
Collins, E., Liu, J. J. W., Bilodeau, M., Burhan, A. M., Enns, M. W., Lavoie, V., Ein, N., Nazarov, A., Auger, É., Balderson, K., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1931305
Kusturica, M. P., Peñarrubia‐María, M. T., Parker, L. A., Mucherino, S., Menditto, E., Orlando, V., & Aznar‐Lou, I. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01340-7
Dervišević, E., Jesenković, D. A., Katica, M., Bešić, A., Ahmed, H., Goletić, T., Terzić, I., Šabić, E., Šuta, N., Fede, M. S., et al. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_573_2026
Bogar, K. F., Chen, C., Brensinger, C. M., Wang, F., Hennessy, S., Nguyen, T. P. P., Bilker, W. B., Miano, T. A., Chung, S. P., Dublin, S., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-109127
Metadata
- Authors
- Dubovsky, S. L., & Marshall, D.
- Affiliations
- University of Colorado Anschutz (US)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 91
- Issue
- 5
- Pages
- 307-334
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W4225388848
- Cited by
- 171
- References
- 105
- Citations by year
- 2026: 40 · 2025: 44 · 2024: 41 · 2023: 38 · 2022: 8
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- benzodiazepines, Z-drugs, anxiety disorders, insomnia, alcohol withdrawal, catatonia, anxious depression, mania, sedation, tolerance (pharmacology and immunology), cognitive impairment, dementia risk, benzodiazepine misuse, benzodiazepine overdose, benzodiazepine receptor, mechanism of action
- MeSH terms
- Alcoholism, Anxiety, Benzodiazepines, Humans, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.